drugset / Trial / NCT01249196
A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease.
Timeline
- Start
- 2010-05
- Primary completion
- 2013-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SK-PC-B70M | Unknown | 200 mg | — |
| Subject | SK-PC-B70M | Unknown | 300 mg | — |